Follow the Kintor Pharmaceutical Ltd. - B stock price and the full directors' dealings record of the company, a listed issuer based in Hong Kong. Shares are quoted on the HK market, under the authority of HKEX. Operating in the Health Care sector, Kintor Pharmaceutical Ltd. - B has recorded 21 public disclosures. Market capitalisation: €773.7m. The latest transaction was reported on 21 July 2026 (Purchase). Among the most active insiders: Tong Youzhi. All data is accessible without an account.
21
Insider Decl.
n/a
Thresholds
€7m
19 ops.
Buy Volume
n/a
n/a
Sell Volume
28Σ signal
Buys €7mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,760 of 28,855 companies
13.9
score / 100
Value
10
Quality
18
FCF yld-21%
Earn yld-24%
EV/EBITDA·
ROE-84%
Gross mgn25%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Kintor Pharmaceutical Ltd. is a biopharmaceutical company focused on developing innovative treatments for serious diseases. It is listed on the Hong Kong Stock Exchange.